BRIEF published on 12/11/2024 at 07:34, 1 year 8 months ago Evotec SE and Novo Nordisk Launch LAB eN² Projects for Drug Discovery Drug Discovery Evotec SE Novo Nordisk Cardiometabolic Diseases LAB EN²
BRIEF published on 12/11/2024 at 07:34, 1 year 8 months ago Evotec SE et Novo Nordisk lancent les projets LAB eN² pour la découverte de médicaments Evotec SE Découverte De Médicaments Novo Nordisk LAB EN² Maladies Cardiométaboliques
PRESS RELEASE published on 12/11/2024 at 07:29, 1 year 8 months ago Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo Nordisk Evotec SE announces selection of first projects for LAB eN² drug discovery accelerator with Novo Nordisk, focusing on cardiometabolic diseases from academic institutions Drug Discovery Evotec SE Novo Nordisk Cardiometabolic Diseases LAB EN²
BRIEF published on 11/29/2024 at 07:36, 1 year 8 months ago Evotec Announces COO Departure and Internal Restructuring Pharmaceuticals Management Change Evotec COO Departure Internal Restructuring
BRIEF published on 11/29/2024 at 07:36, 1 year 8 months ago Evotec annonce le départ de son directeur opérationnel et une restructuration interne Changement De Direction Evotec Médicaments Départ Du COO Restructuration Interne
PRESS RELEASE published on 11/29/2024 at 07:31, 1 year 8 months ago Evotec announces change in Management Board Evotec SE announces the departure of Chief Operating Officer Dr Craig Johnstone effective December 31, 2024, with internal distribution of responsibilities. Management praises Johnstone's contribution and commitment Global Operations Chief Operating Officer Evotec SE Management Board Dr Craig Johnstone
BRIEF published on 11/22/2024 at 17:00, 1 year 8 months ago Evotec SE Comments on Withdrawal of Halozyme's Offer Shareholder Value Evotec SE Acquisition Proposal Halozyme Therapeutics Non-binding Offer
BRIEF published on 11/22/2024 at 17:00, 1 year 8 months ago Evotec SE commente le retrait de l'offre d'Halozyme Evotec SE Valeur Actionnariale Proposition D'acquisition Thérapeutique Halozyme Offre Sans Engagement
PRESS RELEASE published on 11/22/2024 at 16:55, 1 year 8 months ago EQS-Adhoc: Comment on withdrawn non-binding offer Evotec SE acknowledges withdrawal of non-binding offer by Halozyme Therapeutics Inc. for acquisition. Management reiterates confidence in standalone strategy Acquisition Evotec SE Halozyme Therapeutics Inc. Withdrawn Offer Standalone Strategy
BRIEF published on 11/14/2024 at 22:56, 1 year 9 months ago Evotec SE Responds to Interest from Halozyme Evotec SE Takeover Halozyme Therapeutics Expression Of Interest EUR 11 Per Share
Published on 08/19/2026 at 09:05, 2 hours 44 minutes ago BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
Published on 08/19/2026 at 07:00, 4 hours 49 minutes ago Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Olga Kozlova in Dubai
Published on 08/19/2026 at 04:00, 7 hours 49 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 12 hours 39 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/18/2026 at 19:45, 16 hours 4 minutes ago ECC Ventures 5 Corp. Enters Into Business Combination Agreement with Bayrock Resources for Qualifying Transaction
Published on 08/19/2026 at 11:06, 43 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 08/19/2026 at 11:05, 44 minutes ago HMS Bergbau AG announces preliminary financial results for the first half of 2026
Published on 08/19/2026 at 11:00, 49 minutes ago Shelly Group Strengthens European Market Reach Through Partnership with Leading Technology Distributor ALSO
Published on 08/19/2026 at 10:05, 1 hour 43 minutes ago Colt Data Centre Services Appoints Quy Nguyen as Chief Executive Officer
Published on 08/19/2026 at 10:00, 1 hour 48 minutes ago The notes redeemed by Municipality Finance have been removed from trading at Nasdaq Helsinki
Published on 08/18/2026 at 18:00, 17 hours 49 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 18 hours 4 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 16 hours ago Aéroports de Paris S.A - July 2026 traffic figures
